NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
- PMID: 28246602
- PMCID: PMC5299165
- DOI: 10.1155/2017/6917907
NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
Abstract
Background. The NOTCH pathway is known to be important in the pathogenesis of calcific aortic valve disease, possibly through regulators of osteoprotegerin (OPG), receptor activator of nuclear factor κB (RANK), and its ligand (RANKL) system. The purpose of the present study was to search for possible associations between NOTCH1 gene mutations and circulating levels of OPG and soluble RANKL (sRANKL) in patients with aortic stenosis (AS). Methods. The study was performed on 61 patients with AS including 31 with bicuspid and 30 with tricuspid aortic valves. We applied a strategy of targeted mutation screening for 10 out of 34 exons of the NOTCH1 gene by direct sequencing. Serum OPG and sRANKL levels were assessed. Results. In total, 6 genetic variants of the NOTCH1 gene including two new mutations were identified in the study group. In an age- and arterial hypertension-adjusted multivariable regression analysis, the serum OPG levels and the OPG/sRANKL ratio were correlated with NOTCH1 missense variants. All studied missense variants in NOTCH1 gene were found in Ca(2+)-binding EGF motif of the NOTCH extracellular domain bound to Delta-like 4. Conclusion. Our results suggest that the OPG/RANKL/RANK system might be directly influenced by genetic variants of NOTCH1 in aortic valve calcification.
Conflict of interest statement
The authors declare that they have no conflict of interests regarding the publication of this paper.
Figures
Similar articles
-
[Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis].Kardiologiia. 2014;54(6):44-8. doi: 10.18565/cardio.2014.6.44-48. Kardiologiia. 2014. PMID: 25178077 Russian.
-
Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.J Heart Valve Dis. 2008 Mar;17(2):187-93. J Heart Valve Dis. 2008. PMID: 18512489
-
[Expression of osteoprotegerin and soluble ligand of receptor of kappa-B transcription factor activator in the calcification of aortic valve].Biomed Khim. 2019 Jan;65(1):57-62. doi: 10.18097/PBMC20196501057. Biomed Khim. 2019. PMID: 30816098 Russian.
-
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.J Clin Endocrinol Metab. 2007 Dec;92(12):4514-21. doi: 10.1210/jc.2007-0646. Epub 2007 Sep 25. J Clin Endocrinol Metab. 2007. PMID: 17895323 Review.
-
Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.J Clin Endocrinol Metab. 2005 Nov;90(11):6323-31. doi: 10.1210/jc.2005-0794. Epub 2005 Aug 16. J Clin Endocrinol Metab. 2005. PMID: 16105967 Review.
Cited by
-
Identification of pyroptosis-associated genes with diagnostic value in calcific aortic valve disease.Front Cardiovasc Med. 2024 Jan 25;11:1340199. doi: 10.3389/fcvm.2024.1340199. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38333413 Free PMC article.
-
Responsiveness to endurance training can be partly explained by the number of favorable single nucleotide polymorphisms an individual possesses.PLoS One. 2023 Jul 20;18(7):e0288996. doi: 10.1371/journal.pone.0288996. eCollection 2023. PLoS One. 2023. PMID: 37471354 Free PMC article. Clinical Trial.
-
NOTCH1 Gene as a Novel Cause of Thoracic Aortic Aneurysm in Patients with Tricuspid Aortic Valve: Two Cases Reported.Int J Mol Sci. 2023 May 12;24(10):8644. doi: 10.3390/ijms24108644. Int J Mol Sci. 2023. PMID: 37239988 Free PMC article.
-
MiR-217 regulates autophagy through OPG/RANKL/RANK in giant cell tumors.J Orthop Surg Res. 2023 May 10;18(1):346. doi: 10.1186/s13018-023-03826-1. J Orthop Surg Res. 2023. PMID: 37165403 Free PMC article.
-
Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis.Open Heart. 2023 Mar;10(1):e002244. doi: 10.1136/openhrt-2022-002244. Open Heart. 2023. PMID: 36963766 Free PMC article. Review.
References
-
- Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. European Heart Journal. 2012;33:2451–2496. doi: 10.1093/eurheartj/ehs109. - DOI - PubMed
-
- Rajamannan N. M., Evans F. J., Aikawa E., et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group. Circulation. 2011;124(16):1783–1791. doi: 10.1161/circulationaha.110.006767. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
